342 related articles for article (PubMed ID: 34689087)
21. Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions.
Kolodkin-Gal D; Roitman L; Ovadya Y; Azazmeh N; Assouline B; Schlesinger Y; Kalifa R; Horwitz S; Khalatnik Y; Hochner-Ger A; Imam A; Demma JA; Winter E; Benyamini H; Elgavish S; Khatib AA; Meir K; Atlan K; Pikarsky E; Parnas O; Dor Y; Zamir G; Ben-Porath I; Krizhanovsky V
Gut; 2022 Feb; 71(2):345-355. PubMed ID: 33649045
[TBL] [Abstract][Full Text] [Related]
22. A guide to senolytic intervention in neurodegenerative disease.
Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
[TBL] [Abstract][Full Text] [Related]
23. Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models.
Liu Y; Hawkins OE; Vilgelm AE; Pawlikowski JS; Ecsedy JA; Sosman JA; Kelley MC; Richmond A
Clin Cancer Res; 2015 Dec; 21(23):5338-48. PubMed ID: 26152738
[TBL] [Abstract][Full Text] [Related]
24. Senolytics and the compression of late-life mortality.
Kowald A; Kirkwood TBL
Exp Gerontol; 2021 Nov; 155():111588. PubMed ID: 34637949
[TBL] [Abstract][Full Text] [Related]
25. Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions.
Saleh T; Carpenter VJ
Mol Pharmacol; 2021 Dec; 100(6):580-587. PubMed ID: 34544896
[TBL] [Abstract][Full Text] [Related]
26. FOXO4 interacts with p53 TAD and CRD and inhibits its binding to DNA.
Mandal R; Kohoutova K; Petrvalska O; Horvath M; Srb P; Veverka V; Obsilova V; Obsil T
Protein Sci; 2022 May; 31(5):e4287. PubMed ID: 35481640
[TBL] [Abstract][Full Text] [Related]
27. Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway.
Sun X; Shi B; Zheng H; Min L; Yang J; Li X; Liao X; Huang W; Zhang M; Xu S; Zhu Z; Cui H; Liu X
Cell Death Dis; 2018 Feb; 9(3):260. PubMed ID: 29449532
[TBL] [Abstract][Full Text] [Related]
28. Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy.
Carpenter V; Saleh T; Min Lee S; Murray G; Reed J; Souers A; Faber AC; Harada H; Gewirtz DA
Biochem Pharmacol; 2021 Nov; 193():114765. PubMed ID: 34536356
[TBL] [Abstract][Full Text] [Related]
29. Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors.
Zhu Y; Tchkonia T; Fuhrmann-Stroissnigg H; Dai HM; Ling YY; Stout MB; Pirtskhalava T; Giorgadze N; Johnson KO; Giles CB; Wren JD; Niedernhofer LJ; Robbins PD; Kirkland JL
Aging Cell; 2016 Jun; 15(3):428-35. PubMed ID: 26711051
[TBL] [Abstract][Full Text] [Related]
30. Identification of GL-V9 as a novel senolytic agent against senescent breast cancer cells.
Yang D; Tian X; Ye Y; Liang Y; Zhao J; Wu T; Lu N
Life Sci; 2021 May; 272():119196. PubMed ID: 33617857
[TBL] [Abstract][Full Text] [Related]
31. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
Zhu Y; Prata LGPL; Gerdes EOW; Netto JME; Pirtskhalava T; Giorgadze N; Tripathi U; Inman CL; Johnson KO; Xue A; Palmer AK; Chen T; Schaefer K; Justice JN; Nambiar AM; Musi N; Kritchevsky SB; Chen J; Khosla S; Jurk D; Schafer MJ; Tchkonia T; Kirkland JL
EBioMedicine; 2022 Mar; 77():103912. PubMed ID: 35292270
[TBL] [Abstract][Full Text] [Related]
32. Targeting cellular senescence in metabolic disease.
Palmer AK; Tchkonia T; Kirkland JL
Mol Metab; 2022 Dec; 66():101601. PubMed ID: 36116755
[TBL] [Abstract][Full Text] [Related]
33. Promises and challenges of senolytics in skin regeneration, pathology and ageing.
Pils V; Ring N; Valdivieso K; Lämmermann I; Gruber F; Schosserer M; Grillari J; Ogrodnik M
Mech Ageing Dev; 2021 Dec; 200():111588. PubMed ID: 34678388
[TBL] [Abstract][Full Text] [Related]
34. COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms.
Lindemann A; Patel AA; Silver NL; Tang L; Liu Z; Wang L; Tanaka N; Rao X; Takahashi H; Maduka NK; Zhao M; Chen TC; Liu W; Gao M; Wang J; Frank SJ; Hittelman WN; Mills GB; Myers JN; Osman AA
Clin Cancer Res; 2019 Sep; 25(18):5650-5662. PubMed ID: 31308060
[TBL] [Abstract][Full Text] [Related]
35. Attenuation of intrinsic ageing of the skin via elimination of senescent dermal fibroblasts with senolytic drugs.
Kim H; Jang J; Song MJ; Kim G; Park CH; Lee DH; Lee SH; Chung JH
J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):1125-1135. PubMed ID: 35274377
[TBL] [Abstract][Full Text] [Related]
36. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
Khalil R; Diab-Assaf M; Lemaitre JM
Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
[TBL] [Abstract][Full Text] [Related]
37. A geroscience motivated approach to treat Alzheimer's disease: Senolytics move to clinical trials.
Gonzales MM; Krishnamurthy S; Garbarino V; Daeihagh AS; Gillispie GJ; Deep G; Craft S; Orr ME
Mech Ageing Dev; 2021 Dec; 200():111589. PubMed ID: 34687726
[TBL] [Abstract][Full Text] [Related]
38. Cardiac glycosides are broad-spectrum senolytics.
Guerrero A; Herranz N; Sun B; Wagner V; Gallage S; Guiho R; Wolter K; Pombo J; Irvine EE; Innes AJ; Birch J; Glegola J; Manshaei S; Heide D; Dharmalingam G; Harbig J; Olona A; Behmoaras J; Dauch D; Uren AG; Zender L; Vernia S; Martínez-Barbera JP; Heikenwalder M; Withers DJ; Gil J
Nat Metab; 2019 Nov; 1(11):1074-1088. PubMed ID: 31799499
[TBL] [Abstract][Full Text] [Related]
39. A pipeline for senolytics.
Khosla S
J Clin Invest; 2024 May; 134(9):. PubMed ID: 38690734
[TBL] [Abstract][Full Text] [Related]
40. Combined inhibition of class 1-PI3K-alpha and delta isoforms causes senolysis by inducing p21
Neuwahl J; Neumann CA; Fitz AC; Biermann AD; Magel M; Friedrich A; Sellin L; Stork B; Piekorz RP; Proksch P; Budach W; Jänicke RU; Sohn D
Cell Death Dis; 2024 May; 15(5):373. PubMed ID: 38811535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
